$BNGO
Bionano Genomics, Inc. Stock $bngo

$bngo Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000141169024000049 Filed on August 07, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$6.073M	$7.771M
YoY Change	-34.83%	-10.29%
Cost Of Revenue	$14.52M	$5.186M
YoY Change	121.02%	-18.38%
Gross Profit	-$8.446M	$2.585M
YoY Change	-407.24%	12.0%
Gross Profit Margin	-139.07%	33.26%
Selling, General & Admin	$9.464M	$11.56M
YoY Change	-61.99%	-57.09%
% of Gross Profit		447.08%
Research & Development	$4.717M	$6.831M
YoY Change	-65.78%	-53.24%
% of Gross Profit		264.26%
Depreciation & Amortization	$5.680M	$3.039M
YoY Change	54.35%	-9.23%
% of Gross Profit		117.56%
Operating Expenses	$14.18M	$18.39M
YoY Change	-63.34%	-55.74%
Operating Profit	-$43.90M	-$17.02M
YoY Change	-61.22%	-56.63%
Interest Expense	$376.0K	$457.0K
YoY Change	429.58%	517.57%
% of Operating Profit
Other Income/Expense, Net	-$321.0K	$820.0K
YoY Change	-146.86%	128.41%
Pretax Income	-$44.22M	-$16.20M
YoY Change	-60.7%	-58.34%
Income Tax	$24.00K	$26.00K
% Of Pretax Income
Net Earnings	-$44.25M	-$16.22M
YoY Change	-60.69%	-58.31%
Net Earnings / Revenue	-728.57%	-208.78%
Basic Earnings Per Share	-$0.52	-$0.24
Diluted Earnings Per Share	-$0.52	-$0.24
COMMON SHARES
Basic Shares Outstanding	86.00M shares	66.86M shares
Diluted Shares Outstanding	85.87M shares	67.58M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.00M	$18.90M
YoY Change	-81.13%	-75.49%
Cash & Equivalents	$8.800M	$10.40M
Short-Term Investments	$3.200M	$8.500M
Other Short-Term Assets	$15.39M	$15.90M
YoY Change	160.8%	191.85%
Inventory	$16.28M	$23.15M
Prepaid Expenses
Receivables	$5.316M	$6.255M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$46.98M	$60.57M
YoY Change	-55.06%	-50.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$20.00M	$24.86M
YoY Change	-5.98%	22.7%
Goodwill
YoY Change
Intangibles	$11.05M	$30.02M
YoY Change	-69.12%	-20.07%
Long-Term Investments
YoY Change
Other Assets	$2.758M	$5.889M
YoY Change	-72.99%	96.3%
Total Long-Term Assets	$40.38M	$68.80M
YoY Change	-47.8%	-53.77%
TOTAL ASSETS
Total Short-Term Assets	$46.98M	$60.57M
Total Long-Term Assets	$40.38M	$68.80M
Total Assets	$87.36M	$129.4M
YoY Change	-51.97%	-52.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.700M	$8.734M
YoY Change	-43.39%	-26.68%
Accrued Expenses	$5.883M	$5.530M
YoY Change	-49.07%	-33.5%
Deferred Revenue	$1.195M	$1.147M
YoY Change	47.35%	17.28%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$263.0K	$266.0K
YoY Change	-12.33%	-4.66%
Total Short-Term Liabilities	$32.95M	$37.18M
YoY Change	-18.02%	10.97%
LONG-TERM LIABILITIES
Long-Term Debt	$3.551M	$3.564M
YoY Change	-1.36%	-1.11%
Other Long-Term Liabilities	$1.993M	$8.288M
YoY Change	-89.57%	-57.55%
Total Long-Term Liabilities	$5.544M	$11.85M
YoY Change	-75.58%	-48.75%
TOTAL LIABILITIES
Total Short-Term Liabilities	$32.95M	$37.18M
Total Long-Term Liabilities	$5.544M	$11.85M
Total Liabilities	$38.49M	$49.03M
YoY Change	-38.81%	-13.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$673.1M	-$628.9M
YoY Change	25.27%	48.05%
Common Stock	$720.4M	$709.2M
YoY Change	9.75%	10.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$48.87M	$80.34M
YoY Change
Total Liabilities & Shareholders Equity	$87.36M	$129.4M
YoY Change	-51.97%	-52.33%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$44.25M	-$16.22M
YoY Change	-60.69%	-58.31%
Depreciation, Depletion And Amortization	$5.680M	$3.039M
YoY Change	54.35%	-9.23%
Cash From Operating Activities	-$13.31M	-$20.98M
YoY Change	-49.38%	-42.83%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$77.00K
YoY Change	-100.0%	-84.93%
Acquisitions
YoY Change
Other Investing Activities	-$5.375M	$28.71M
YoY Change	-116.04%	-4.58%
Cash From Investing Activities	-$5.375M	$28.63M
YoY Change	-116.08%	-3.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.021M	-1.978M
YoY Change	-52.18%	-111.06%
NET CHANGE
Cash From Operating Activities	-13.31M	-20.98M
Cash From Investing Activities	-5.375M	28.63M
Cash From Financing Activities	6.021M	-1.978M
Net Change In Cash	-12.66M	5.675M
YoY Change	-164.18%	-47.26%
FREE CASH FLOW
Cash From Operating Activities	-$13.31M	-$20.98M
Capital Expenditures	$0.00	$77.00K
Free Cash Flow	-$13.31M	-$21.06M
YoY Change	-49.53%	-43.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Assets Current AssetsCurrent	60568000	usd
CY2024Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	400000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24863000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4221000	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3402000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7431000	usd
CY2023Q4	us-gaap	Assets Assets	214404000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10384000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8089000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	783000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	272000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	37175000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2242000	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3564000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	5774000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	272000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	49027000	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	70776000	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	709187000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-628854000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	80337000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	129364000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16540000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16608000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	31092000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	363000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	820000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	359000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16198000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-38879000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-16224000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-38912000	usd
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.24
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.79
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60175000	shares
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-16224000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-38912000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-10000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-28000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	13000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	355000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-26000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-38557000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-47672000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2583000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2163000	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70776000	shares
CY2024Q2	us-gaap	Costs And Expenses CostsAndExpenses	19603000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	41546000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-17018000	usd
CY2024Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	457000	usd
CY2023Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	689000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	27000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	814000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-75224000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-37124000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	459000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	231486000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-39238000	usd
CY2023Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.1
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P6M
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.1
	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	11008000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2024Q2	us-gaap	Restricted Investments Current RestrictedInvestmentsCurrent	0	usd
CY2023Q4	us-gaap	Restricted Investments Current RestrictedInvestmentsCurrent	35117000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	140118000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	400000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23345000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5633000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3503000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	30021000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	33974000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5889000	usd
CY2024Q2	us-gaap	Assets Assets	129364000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	8734000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5530000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1147000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2139000	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	266000	usd
CY2024Q2	bngo	Purchase Option Liability Fair Value Current PurchaseOptionLiabilityFairValueCurrent	0	usd
CY2023Q4	bngo	Purchase Option Liability Fair Value Current PurchaseOptionLiabilityFairValueCurrent	8534000	usd
CY2024Q2	bngo	Notes Payable Fair Value Disclosure Current NotesPayableFairValueDisclosureCurrent	19359000	usd
CY2023Q4	bngo	Notes Payable Fair Value Disclosure Current NotesPayableFairValueDisclosureCurrent	69803000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	100028000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3590000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3585000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	10890000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	154000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	118247000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45752000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45752000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	5000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	677337000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-581208000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	23000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	96157000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	214404000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16077000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11132000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11700000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28547000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	52913000	usd
CY2024Q2	us-gaap	Restructuring Costs RestructuringCosts	1215000	usd
CY2023Q2	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-330000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.24
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.79
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	67583000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67583000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60175000	shares
CY2024Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	15000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	365000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16211000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	249398000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	23000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3882000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14848000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3932000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17802000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	92000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-38912000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	355000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	214756000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15060000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-31422000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-39000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	82771000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11182000	usd
CY2024Q2	bngo	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	2000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	10000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-16224000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	13000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	80337000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-47646000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-76038000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5995000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6487000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	102000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	102000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	912000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	226000	usd
	bngo	Non Cash Lease Expense NonCashLeaseExpense	113000	usd
	bngo	Non Cash Lease Expense NonCashLeaseExpense	20000	usd
	bngo	Gain Loss On Modification Of Lease GainLossOnModificationOfLease	73000	usd
	bngo	Gain Loss On Modification Of Lease GainLossOnModificationOfLease	0	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-18000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-23000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5598000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	7814000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-5116000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2218000	usd
	bngo	Fair Value Option Liability And Notes Payable Changes In Fair Value Gain Loss FairValueOptionLiabilityAndNotesPayableChangesInFairValueGainLoss	7084000	usd
	bngo	Fair Value Option Liability And Notes Payable Changes In Fair Value Gain Loss FairValueOptionLiabilityAndNotesPayableChangesInFairValueGainLoss	0	usd
	bngo	Gain Loss On Issuance Of Debt GainLossOnIssuanceOfDebt	-1890000	usd
	bngo	Gain Loss On Issuance Of Debt GainLossOnIssuanceOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3965000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	448000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-374000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	bngo	Cost Of Leased Equipment Sold To Customer CostOfLeasedEquipmentSoldToCustomer	210000	usd
	bngo	Cost Of Leased Equipment Sold To Customer CostOfLeasedEquipmentSoldToCustomer	88000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3064000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	590000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1073000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7345000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1129000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1785000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1545000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	587000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1648000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-791000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2078000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2069000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-49109000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-69109000	usd
	bngo	Proceeds From Business Combination Two Return Of Purchase Consideration From Escrow ProceedsFromBusinessCombinationTwoReturnOfPurchaseConsiderationFromEscrow	0	usd
	bngo	Proceeds From Business Combination Two Return Of Purchase Consideration From Escrow ProceedsFromBusinessCombinationTwoReturnOfPurchaseConsiderationFromEscrow	96000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	103000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	839000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	151585000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	227905000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	46879000	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	0	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	32000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	76217000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	46104000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	28000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	22000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	27602000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	33487000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1362000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	837000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	10000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	92000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	23000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	18000000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	61001000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1444000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	5375000	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-23596000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32743000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-27000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3485000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9765000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	18348000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5491000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21833000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15256000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10425000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14856000	usd
CY2024Q2	us-gaap	Restricted Cash RestrictedCash	11408000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	400000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21833000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15256000	usd
	us-gaap	Interest Paid Net InterestPaidNet	9670000	usd
	us-gaap	Interest Paid Net InterestPaidNet	149000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1340000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1291000	usd
	bngo	Transfer Of Instruments And Servers TransferOfInstrumentsAndServers	4490000	usd
	bngo	Transfer Of Instruments And Servers TransferOfInstrumentsAndServers	4615000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	104000	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	65000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10400000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	8500000	usd
CY2024Q2	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	11400000	usd
CY2024Q2	bngo	Debt Instrument Covenant Cash Balance Maximum DebtInstrumentCovenantCashBalanceMaximum	11000000.0	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-628900000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-49100000	usd
	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	1.15
CY2024Q2	bngo	Debt Instrument Redemption Amount DebtInstrumentRedemptionAmount	31800000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	18000000.0	usd
CY2024Q2	us-gaap	Debt Instrument Repurchase Amount DebtInstrumentRepurchaseAmount	20700000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	400000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2024Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	3700000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	45381000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4041000	shares
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7771000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8662000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16540000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16077000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7771000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8662000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16540000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16077000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1400000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.579
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.308
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.113
CY2024Q2	bngo	Contract With Customer Liability Revenue Recognized Excluding Deferred Amounts ContractWithCustomerLiabilityRevenueRecognizedExcludingDeferredAmounts	400000	usd
CY2023Q2	bngo	Contract With Customer Liability Revenue Recognized Excluding Deferred Amounts ContractWithCustomerLiabilityRevenueRecognizedExcludingDeferredAmounts	400000	usd
	bngo	Contract With Customer Liability Revenue Recognized Excluding Deferred Amounts ContractWithCustomerLiabilityRevenueRecognizedExcludingDeferredAmounts	1000000.0	usd
	bngo	Contract With Customer Liability Revenue Recognized Excluding Deferred Amounts ContractWithCustomerLiabilityRevenueRecognizedExcludingDeferredAmounts	1100000	usd
CY2024Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	6693000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	9802000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	7315000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	438000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	483000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	293000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6255000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9319000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7022000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	293000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-5000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	36000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	262000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	483000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-9000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	54000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	438000	usd
CY2024Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	8932000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	7567000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4635000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9790000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	9582000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10245000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	23149000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	27602000	usd
CY2024Q2	bngo	Inventory Current InventoryCurrent	19475000	usd
CY2023Q4	bngo	Inventory Current InventoryCurrent	22892000	usd
CY2024Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	3674000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	4710000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	46800000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16881000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	29919000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	48380000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14508000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33872000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3605000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5030000	usd
CY2024Q2	us-gaap	Deposit Liability Current DepositLiabilityCurrent	17000	usd
CY2023Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	17000	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	1065000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1099000	usd
CY2024Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	44000	usd
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	512000	usd
CY2024Q2	bngo	Professional Fees And Royalties Current ProfessionalFeesAndRoyaltiesCurrent	299000	usd
CY2023Q4	bngo	Professional Fees And Royalties Current ProfessionalFeesAndRoyaltiesCurrent	387000	usd
CY2024Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	244000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	391000	usd
CY2024Q2	bngo	Accrued Clinical Study Fees Current AccruedClinicalStudyFeesCurrent	1000	usd
CY2023Q4	bngo	Accrued Clinical Study Fees Current AccruedClinicalStudyFeesCurrent	138000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	255000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	515000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5530000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8089000	usd
CY2024Q2	bngo	Debt Instrument Covenant Cash Balance Maximum DebtInstrumentCovenantCashBalanceMaximum	11000000.0	usd
CY2024Q2	us-gaap	Debt Instrument Repurchase Amount DebtInstrumentRepurchaseAmount	49500000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	18000000.0	usd
CY2024Q2	us-gaap	Debt Instrument Repurchase Amount DebtInstrumentRepurchaseAmount	20700000	usd
CY2024Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1444000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1444000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
CY2024Q2	us-gaap	Interest Expense Other InterestExpenseOther	74000	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	74000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	195000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	149000	usd
CY2024Q2	bngo	Changes In Estimated Fair Value Interest And Redemption Payments Recorded In Other Income Expense Net ChangesInEstimatedFairValueInterestAndRedemptionPaymentsRecordedInOtherIncomeExpenseNet	298000	usd
CY2023Q2	bngo	Changes In Estimated Fair Value Interest And Redemption Payments Recorded In Other Income Expense Net ChangesInEstimatedFairValueInterestAndRedemptionPaymentsRecordedInOtherIncomeExpenseNet	0	usd
	bngo	Changes In Estimated Fair Value Interest And Redemption Payments Recorded In Other Income Expense Net ChangesInEstimatedFairValueInterestAndRedemptionPaymentsRecordedInOtherIncomeExpenseNet	-855000	usd
	bngo	Changes In Estimated Fair Value Interest And Redemption Payments Recorded In Other Income Expense Net ChangesInEstimatedFairValueInterestAndRedemptionPaymentsRecordedInOtherIncomeExpenseNet	0	usd
CY2024Q2	bngo	Other Nonoperating Income Expense Gross OtherNonoperatingIncomeExpenseGross	-492000	usd
CY2023Q2	bngo	Other Nonoperating Income Expense Gross OtherNonoperatingIncomeExpenseGross	-256000	usd
	bngo	Other Nonoperating Income Expense Gross OtherNonoperatingIncomeExpenseGross	-579000	usd
	bngo	Other Nonoperating Income Expense Gross OtherNonoperatingIncomeExpenseGross	-139000	usd
CY2024Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3965000	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3965000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q2	bngo	Gain Loss On Issuance Of Debt GainLossOnIssuanceOfDebt	-1890000	usd
CY2023Q2	bngo	Gain Loss On Issuance Of Debt GainLossOnIssuanceOfDebt	0	usd
	bngo	Gain Loss On Issuance Of Debt GainLossOnIssuanceOfDebt	-1890000	usd
	bngo	Gain Loss On Issuance Of Debt GainLossOnIssuanceOfDebt	0	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	363000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-330000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-998000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-288000	usd
CY2023Q3	bngo	Stockholders Equity Note Stock Split Multiplier Per Share StockholdersEquityNoteStockSplitMultiplierPerShare	5.90
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	14000000	shares
CY2024Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.26
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	17600000	usd
CY2024Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	400000	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	21696000	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.38
CY2023	bngo	Class Of Warrant Or Right Weighted Average Remaining Contractual Term Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageRemainingContractualTermOfWarrantsOrRights	P4Y9M10D
CY2023Q4	bngo	Class Of Warrant Or Right Aggregate Intrinsic Value Of Warrants Or Rights ClassOfWarrantOrRightAggregateIntrinsicValueOfWarrantsOrRights	0	usd
	bngo	Class Of Warrant Or Right Number Of Securities Granted In Period ClassOfWarrantOrRightNumberOfSecuritiesGrantedInPeriod	10931000	shares
	bngo	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Granted In Period ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsGrantedInPeriod	0.82
	bngo	Class Of Warrant Or Right Number Of Securities Exercised In Period ClassOfWarrantOrRightNumberOfSecuritiesExercisedInPeriod	2197000	shares
	bngo	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised In Period ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercisedInPeriod	0
	bngo	Class Of Warrant Or Right Aggregate Intrinsic Value Exercised In Period Of Warrants Or Rights ClassOfWarrantOrRightAggregateIntrinsicValueExercisedInPeriodOfWarrantsOrRights	0	usd
	bngo	Class Of Warrant Or Right Number Of Securities Canceled In Period ClassOfWarrantOrRightNumberOfSecuritiesCanceledInPeriod	0	shares
	bngo	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Canceled In Period ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsCanceledInPeriod	0
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	30430000	shares
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.41
	bngo	Class Of Warrant Or Right Weighted Average Remaining Contractual Term Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageRemainingContractualTermOfWarrantsOrRights	P4Y5M4D
CY2024Q2	bngo	Class Of Warrant Or Right Aggregate Intrinsic Value Of Warrants Or Rights ClassOfWarrantOrRightAggregateIntrinsicValueOfWarrantsOrRights	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3268000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.79
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1663000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.93
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	570000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	23.06
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4361000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.92
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M23D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1701000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	28.55
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y6M10D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	0	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.67
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.67
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2583000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3932000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5598000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7814000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.043
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.039
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.043
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.039
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.864
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.805
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.862
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.744
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M12D
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M24D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1414000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	166000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2608000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	338000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	545000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	346000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	254000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	356000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	0	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	365000	usd
CY2024Q2	bngo	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	0	usd
CY2024Q2	bngo	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	5230000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4821000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	6801000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	440000	usd
CY2024Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2971000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4381000	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	3830000	usd
CY2024Q2	bngo	Commitments And Contingencies Severance Payment Notice Period CommitmentsAndContingenciesSeverancePaymentNoticePeriod	P60D
CY2024Q2	bngo	Fair Value Number Of Independent Milestones FairValueNumberOfIndependentMilestones	2	milestone
	bngo	Business Combination Contingent Consideration Liability Term BusinessCombinationContingentConsiderationLiabilityTerm	P5Y
CY2023Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	4	security
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	15	security
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	0	security
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	2	security
	bngo	Debt Securities Available For Sale Number Of Positions Sold DebtSecuritiesAvailableForSaleNumberOfPositionsSold	18	security
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	33300000	usd
	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	-18000.000	usd
CY2024Q2	us-gaap	Interest Receivable InterestReceivable	100000	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	300000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	8519000	usd
CY2024Q2	bngo	Debt Securities Available For Sale Unrealized Gain Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAvailableForSaleUnrealizedGainMaturityAllocatedAndSingleMaturityDateYearOne	0	usd
CY2024Q2	bngo	Debt Securities Available For Sale Unrealized Loss Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAvailableForSaleUnrealizedLossMaturityAllocatedAndSingleMaturityDateYearOne	3000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	8516000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	48828000	usd
CY2023Q4	bngo	Debt Securities Available For Sale Unrealized Gain Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAvailableForSaleUnrealizedGainMaturityAllocatedAndSingleMaturityDateYearOne	4000	usd
CY2023Q4	bngo	Debt Securities Available For Sale Unrealized Loss Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAvailableForSaleUnrealizedLossMaturityAllocatedAndSingleMaturityDateYearOne	9000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	48823000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	8516000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	3000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	8516000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	3000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	2362000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	5000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	10001000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	4000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	12363000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	9000	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
bngo-20240630_cal.xml	Edgar Link	unprocessable
0001411690-24-000049-index-headers.html	Edgar Link	pending
0001411690-24-000049-index.html	Edgar Link	pending
0001411690-24-000049.txt	Edgar Link	pending
0001411690-24-000049-xbrl.zip	Edgar Link	pending
bngo-20240630.htm	Edgar Link	pending
bngo-20240630.xsd	Edgar Link	pending
bngo-20240630xexx311.htm	Edgar Link	pending
bngo-20240630xexx312.htm	Edgar Link	pending
bngo-20240630xexx321.htm	Edgar Link	pending
bngo-ex1010princetonlicens.htm	Edgar Link	pending
bngo-ex1011firstamendmentt.htm	Edgar Link	pending
bngo-ex1012secondamendment.htm	Edgar Link	pending
bngo-ex1013fourthamendment.htm	Edgar Link	pending
bngo-ex1014qbiotechnologyc.htm	Edgar Link	pending
bngo-ex1015amendmenttoqbio.htm	Edgar Link	pending
bngo-ex1016nyulicenseagree.htm	Edgar Link	pending
bngo-ex1017pacbiooptionand.htm	Edgar Link	pending
bngo-ex108skorpiosmasterse.htm	Edgar Link	pending
bngo-ex109paramitmsafeb182.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_01.jpg	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
image_10.jpg	Edgar Link	pending
image_101.jpg	Edgar Link	pending
image_102.jpg	Edgar Link	pending
image_104.jpg	Edgar Link	pending
image_106.jpg	Edgar Link	pending
image_107.jpg	Edgar Link	pending
image_108.jpg	Edgar Link	pending
image_11.jpg	Edgar Link	pending
image_110.jpg	Edgar Link	pending
image_111.jpg	Edgar Link	pending
image_112.jpg	Edgar Link	pending
image_113.jpg	Edgar Link	pending
image_116.jpg	Edgar Link	pending
image_118.jpg	Edgar Link	pending
image_125.jpg	Edgar Link	pending
image_127.jpg	Edgar Link	pending
image_128.jpg	Edgar Link	pending
image_129.jpg	Edgar Link	pending
image_130.jpg	Edgar Link	pending
image_131.jpg	Edgar Link	pending
image_133.jpg	Edgar Link	pending
bngo-20240630_def.xml	Edgar Link	unprocessable
bngo-20240630_lab.xml	Edgar Link	unprocessable
bngo-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bngo-20240630_htm.xml	Edgar Link	completed
image_135.jpg	Edgar Link	pending
image_138.jpg	Edgar Link	pending
image_140.jpg	Edgar Link	pending
image_141.jpg	Edgar Link	pending
image_142.jpg	Edgar Link	pending
image_146.jpg	Edgar Link	pending
image_147.jpg	Edgar Link	pending
image_148.jpg	Edgar Link	pending
image_149.jpg	Edgar Link	pending
image_150.jpg	Edgar Link	pending
image_151.jpg	Edgar Link	pending
image_152.jpg	Edgar Link	pending
image_153.jpg	Edgar Link	pending
image_154.jpg	Edgar Link	pending
image_155.jpg	Edgar Link	pending
image_156.jpg	Edgar Link	pending
image_158.jpg	Edgar Link	pending
image_159.jpg	Edgar Link	pending
image_16.jpg	Edgar Link	pending
image_168.jpg	Edgar Link	pending
image_169.jpg	Edgar Link	pending
image_171.jpg	Edgar Link	pending
image_176.jpg	Edgar Link	pending
image_178.jpg	Edgar Link	pending
image_179.jpg	Edgar Link	pending
image_184.jpg	Edgar Link	pending
image_187.jpg	Edgar Link	pending
image_189.jpg	Edgar Link	pending
image_191.jpg	Edgar Link	pending
image_192.jpg	Edgar Link	pending
image_193.jpg	Edgar Link	pending
image_197.jpg	Edgar Link	pending
image_20.jpg	Edgar Link	pending
image_203.jpg	Edgar Link	pending
image_205.jpg	Edgar Link	pending
image_210.jpg	Edgar Link	pending
image_212.jpg	Edgar Link	pending
image_216.jpg	Edgar Link	pending
image_220.jpg	Edgar Link	pending
image_224.jpg	Edgar Link	pending
image_228.jpg	Edgar Link	pending
image_230.jpg	Edgar Link	pending
image_231.jpg	Edgar Link	pending
image_234.jpg	Edgar Link	pending
image_236.jpg	Edgar Link	pending
image_237.jpg	Edgar Link	pending
image_24.jpg	Edgar Link	pending
image_242.jpg	Edgar Link	pending
image_244.jpg	Edgar Link	pending
image_246.jpg	Edgar Link	pending
image_247.jpg	Edgar Link	pending
image_248.jpg	Edgar Link	pending
image_251.jpg	Edgar Link	pending
image_252.jpg	Edgar Link	pending
image_257.jpg	Edgar Link	pending
image_258.jpg	Edgar Link	pending
image_259.jpg	Edgar Link	pending
image_262.jpg	Edgar Link	pending
image_264.jpg	Edgar Link	pending
image_269.jpg	Edgar Link	pending
image_274.jpg	Edgar Link	pending
image_275.jpg	Edgar Link	pending
image_277.jpg	Edgar Link	pending
image_279.jpg	Edgar Link	pending
image_283.jpg	Edgar Link	pending
image_285.jpg	Edgar Link	pending
image_290.jpg	Edgar Link	pending
image_292.jpg	Edgar Link	pending
image_294.jpg	Edgar Link	pending
image_296.jpg	Edgar Link	pending
image_298.jpg	Edgar Link	pending
image_299.jpg	Edgar Link	pending
image_3.jpg	Edgar Link	pending
image_31.jpg	Edgar Link	pending
image_32.jpg	Edgar Link	pending
image_34.jpg	Edgar Link	pending
image_36.jpg	Edgar Link	pending
image_3a.jpg	Edgar Link	pending
image_42.jpg	Edgar Link	pending
image_43.jpg	Edgar Link	pending
image_46.jpg	Edgar Link	pending
image_47.jpg	Edgar Link	pending
image_52.jpg	Edgar Link	pending
image_6.jpg	Edgar Link	pending
image_60.jpg	Edgar Link	pending
image_61.jpg	Edgar Link	pending
image_62.jpg	Edgar Link	pending
image_64.jpg	Edgar Link	pending
image_65.jpg	Edgar Link	pending
image_66.jpg	Edgar Link	pending
image_67.jpg	Edgar Link	pending
image_7.jpg	Edgar Link	pending
image_71.jpg	Edgar Link	pending
image_73.jpg	Edgar Link	pending
image_75.jpg	Edgar Link	pending
image_76.jpg	Edgar Link	pending
image_77.jpg	Edgar Link	pending
image_78.jpg	Edgar Link	pending
image_79.jpg	Edgar Link	pending
image_80.jpg	Edgar Link	pending
image_81.jpg	Edgar Link	pending
image_82.jpg	Edgar Link	pending
image_83.jpg	Edgar Link	pending
image_84.jpg	Edgar Link	pending
image_85.jpg	Edgar Link	pending
image_88.jpg	Edgar Link	pending
image_90.jpg	Edgar Link	pending
image_91.jpg	Edgar Link	pending
image_94.jpg	Edgar Link	pending
image_95.jpg	Edgar Link	pending
image_96.jpg	Edgar Link	pending
image_99.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNGO
Bionano Genomics, Inc. Stock $bngo

2024 Q3 Form 10-Q Financial Statement

#000141169024000049 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNGO Bionano Genomics, Inc. Stock $bngo

2024 Q3 Form 10-Q Financial Statement

#000141169024000049 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNGO
Bionano Genomics, Inc. Stock $bngo